Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-26

Clinical Trial Update: Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating morphine analgesia after radiofrequency ablation of painful bone metastases in cancer patients; the study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: Institut Bergonié | Conditions: Metastatic Cancer, Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-03-26